Yingze Wei
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Genomics, phytochemicals, and oxidative stress 5
- RNA modifications and cancer 5
- Ubiquitin and proteasome pathways 3
- RNA Research and Splicing 3
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 3
- Co-authors
- Xiaoxia Jin (8 shared papers)Nong Zhang (5 shared papers)Shuyun Yang (4 shared papers)Tao Jiang (2 shared papers)Lili Ji (2 shared papers)Qingying Wang (4 shared papers)Jiawen Zhang (4 shared papers)Shuyang Wang (2 shared papers)
- Journals
- Journal of Molecular Histology (2 papers)Cancer Medicine (2 papers)Oncotarget (2 papers)Anti-Cancer Agents in Medicinal Chemistry (2 papers)International Journal of Gynecological Cancer (1 paper)
- Partner nations
- ChinaUnited StatesPortugal
In The Last Decade
Yingze Wei
25 papers receiving 589 citations
Peers
Comparison fields: 5 of 76
- Geriatrics and Gerontology 72
- Cancer Research 117
- Toxicology 26
- Molecular Biology 328
- Oncology 77
Countries citing papers authored by Yingze Wei
This map shows the geographic impact of Yingze Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingze Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingze Wei more than expected).
Fields of papers citing papers by Yingze Wei
This network shows the impact of papers produced by Yingze Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingze Wei. The network helps show where Yingze Wei may publish in the future.
Co-authors
The 25 scholars most cited alongside Yingze Wei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 82 | |
| 2 | 2019 | 65 | |
| 3 | Correlation of Nrf2, NQO1, MRP1, cmyc and p53 in colorectal cancer and their relationships to clinicopathologic features and survival. | 2014 | 60 |
| 4 | 2014 | 43 | |
| 5 | 2019 | 40 | |
| 6 | 2016 | 40 | |
| 7 | 2018 | 37 | |
| 8 | 2016 | 26 | |
| 9 | 2016 | 26 | |
| 10 | 2017 | 21 | |
| 11 | 2019 | 20 | |
| 12 | 2018 | 19 | |
| 13 | 2017 | 17 | |
| 14 | 2016 | 16 | |
| 15 | 2014 | 16 | |
| 16 | 2016 | 12 | |
| 17 | 2015 | 9 | |
| 18 | 2013 | 9 | |
| 19 | 2020 | 9 | |
| 20 | 2019 | 8 |
About Yingze Wei
Yingze Wei is a scholar working on Molecular Biology, Cancer Research, Immunology, Pathology and Forensic Medicine and Geriatrics and Gerontology, having authored 26 papers that have together received 592 indexed citations. Recurring topics across this work include Genomics, phytochemicals, and oxidative stress (5 papers), RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (5 papers), Sirtuins and Resveratrol in Medicine (4 papers), Ubiquitin and proteasome pathways (3 papers), RNA Research and Splicing (3 papers), MicroRNA in disease regulation (3 papers) and Chronic Kidney Disease and Diabetes (2 papers). The work is most often cited by research in Geriatrics and Gerontology (72 citations), Cancer Research (117 citations), Toxicology (26 citations), Molecular Biology (328 citations) and Oncology (77 citations). Yingze Wei has collaborated with scholars based in China, United States and Portugal. Frequent co-authors include Xiaoxia Jin, Nong Zhang, Shuyun Yang, Tao Jiang, Lili Ji, Qingying Wang, Jiawen Zhang, Shuyang Wang, Jianyun Zhou and Feng Xu. Their work appears in journals such as Journal of Molecular Histology, Cancer Medicine, Oncotarget, Anti-Cancer Agents in Medicinal Chemistry and International Journal of Gynecological Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.